NewSquare Capital’s Exact Sciences EXAS Stock Holding History

NewSquare Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-138	Closed	-$9.36K	–	884
2023 Q1	$9.36K	Buy	+138	New	+$8.87K	﹤0.01%	358

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

NewSquare Capital's EXAS Position: Q2 2023 in Review

NewSquare Capital sold out of Exact Sciences (EXAS) in Q2 2023, closing a stake of 138 shares — an estimated $9.36K sold.

NewSquare Capital first reported a position in EXAS in Q1 2023 and held it in 1 quarter. The position peaked at $9.36K in Q1 2023. 654 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

NewSquare Capital reported no remaining Exact Sciences position as of Q2 2023 after selling out during the quarter.
NewSquare Capital sold 138 Exact Sciences shares in Q2 2023, an estimated $9.36K.
NewSquare Capital first reported a position in Exact Sciences in Q1 2023 and held it in 1 quarter.
NewSquare Capital's Exact Sciences position peaked at $9.36K in Q1 2023.
654 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on NewSquare Capital's 13F filing for Q2 2023, filed 3 Aug 2023.